2019 tables: Institutions - chemistry - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share* 2017–2018
1 Merck & Co., Inc., United States of America (USA) 22.44 22.27 37 -6.7%
2 IBM Corporation, United States of America (USA) 17.77 20.94 53 10.8%
3 F. Hoffmann-La Roche AG, Switzerland 16.85 15.16 32 -15.4%
4 Bristol-Myers Squibb (BMS), United States of America (USA) 11.35 14.77 25 22.4%
5 Pfizer Inc., United States of America (USA) 13.24 12.07 25 -14.3%
6 AstraZeneca plc, United Kingdom (UK) 10.93 10.87 52 -6.4%
7 DowDuPont Inc., United States of America (USA) 9.81 10.05 28 -3.7%
8 Thermo Fisher Scientific Inc., United States of America (USA) 4.37 9.47 37 103.6%
9 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 7.50 7.74 21 -2.9%
10 Novartis International AG, Switzerland 11.74 6.74 27 -46.0%
11 BASF SE, Germany 6.69 6.41 32 -10.0%
12 Samsung Group, South Korea 6.92 6.05 27 -17.8%
13 Johnson & Johnson, United States of America (USA) 6.09 5.95 16 -8.2%
14 Jinchuan Group Co., Ltd., China 3.35 5.59 28 56.8%
15 China State Shipbuilding Corporation Limited (CSSC), China 2.71 5.25 67 82.6%
16 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 5.33 4.78 15 -15.7%
17 AbbVie Inc., United States of America (USA) 4.21 4.58 12 2.2%
18 Bruker Corporation, United States of America (USA) 4.65 4.41 24 -10.9%
19 FiberHome Technologies Group, China 2.76 4.27 42 45.4%
20 UCB S.A., Belgium 1.83 4.20 11 115.3%
21 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 4.07 4.08 9 -5.8%
22 Shanghai Jiahua Poly Battery Technology Co., Ltd., China 0.60 3.58 11 460.8%
23 Bayer AG, Germany 1.74 3.57 13 92.7%
24 Toyota Group, Japan 5.01 3.37 11 -36.8%
25 Sanofi, France 1.81 3.29 5 70.5%
26 Shimadzu Corporation, Japan 1.54 3.23 10 96.6%
27 Nippon Telegraph and Telephone Corporation (NTT), Japan 0.09 3.10 7 3203.9%
28 China National Chemical Corporation (ChemChina), China 3.22 2.97 11 -13.2%
29 Center for Nanotechnology GmbH (CeNTech GmbH), Germany 2.26 2.83 15 17.6%
30 Chengdu Institute of Organic Chemistry (CIOC), CAS, China 2.72 2.72 8 -6.1%
31 Sociedad Europea de Análisis Diferencial de Movilidad SL (SEADM), Spain 2.56 4 N/A
32 General Electric Company (GE), United States of America (USA) 0.79 2.56 8 205.1%
33 Synfuels China Technology Co., Ltd., China 1.23 2.52 14 91.7%
34 Abbott Laboratories, United States of America (USA) 2.50 3 N/A
35 Saudi Basic Industries Corporation (SABIC), Saudi Arabia 1.76 2.43 7 29.4%
36 Waters Corporation, United States of America (USA) 2.85 2.40 8 -20.8%
37 Amgen Inc., United States of America (USA) 3.55 2.38 7 -37.1%
38 JEOL Ltd., Japan 2.39 2.35 15 -7.4%
39 Johnson Matthey (JM), United Kingdom (UK) 1.64 2.34 7 33.9%
40 BGI, China 0.36 2.15 6 467.0%
41 Eli Lilly and Company, United States of America (USA) 5.74 2.12 11 -65.3%
42 Agilent Technologies, Inc., United States of America (USA) 2.29 2.11 5 -13.2%
43 Takeda Pharmaceutical Company Limited, Japan 1.58 2.10 6 24.7%
44 Rigaku Corporation, Japan 2.41 2.09 13 -18.7%
45 Novo Nordisk A/S, Denmark 2.48 2.06 6 -21.9%
46 Metrohm DropSens S.L., Spain 1.00 2.00 2 88.0%
46 Regeneron Pharmaceuticals, Inc., United States of America (USA) 1.03 2.00 2 83.0%
46 Novilytic, LLC, United States of America (USA) 2.00 2 N/A
46 Piramal Enterprises Limited, India 2.00 2 N/A
47 Merck KGaA, Germany 2.71 1.93 12 -32.8%
48 Thales S.A., France 1.23 1.90 16 44.9%
49 Hitachi, Ltd., Japan 2.00 1.84 11 -13.4%
50 Peptide Institute, Inc., Japan 0.88 1.83 2 97.0%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.